Related Experiment Video
Updated: Aug 9, 2026

Using 2-Photon Microscopy to Quantify the Effects of Chronic Unilateral Ureteral Obstruction on Glomerular Processes
Published on: March 4, 2022
[Microalbuminuria--underestimated cardiovascular risk factor]
Michał Nowicki1, Ewa Smoleń, Magdalena Szklarek
1Klinika Nefrologii, Hipertensjologii i Transplantologii Nerek Uniwersytetu Medycznego w Lodzi. nefro@wp.pl
Abstract:
The term microalbuminuria stands for an increased urinary excretion of albumin undetectable by routine methods for determination of proteinuria. Microalbuminuria is found in a substantial proportion of patients with diabetes, arterial hypertension and in the elderly. New data has provided strong evidence that albuminuria not only indicates early glomerular damage but also widespread endothelial dysfunction, early atherogenesis and increased cardiovascular and cerebrovascular risk. It has been shown that angiotensin converting enzyme inhibitors have a potential to decrease urinary albumin excretion, which confirms their well-established nephro- and vasoprotective action.
Insights
Microalbuminuria, or increased albumin excretion, signals early kidney damage and cardiovascular risk in patients with diabetes and hypertension. Angiotensin converting enzyme inhibitors show promise in reducing this excretion, highlighting their protective effects.
Area of Science:
- Nephrology
- Cardiology
- Endocrinology
Context:
- Microalbuminuria is a marker of early kidney damage.
- It is prevalent in patients with diabetes and hypertension.
- It indicates endothelial dysfunction and increased cardiovascular risk.
Purpose:
- To define microalbuminuria and its clinical significance.
- To highlight the association between microalbuminuria and cardiovascular/cerebrovascular risk.
- To discuss the nephro- and vasoprotective effects of ACE inhibitors.
Summary:
- Microalbuminuria signifies increased urinary albumin excretion, often missed by standard tests.
- It is linked to glomerular damage, endothelial dysfunction, and heightened cardiovascular and cerebrovascular risks.
- Angiotensin converting enzyme inhibitors demonstrate potential in reducing albuminuria, supporting their protective roles.
Impact:
- Early detection of microalbuminuria can guide interventions.
- Understanding its link to cardiovascular risk aids in patient management.
- ACE inhibitors offer a therapeutic strategy for mitigating kidney and vascular damage.
Related Concept Videos
Diabetic Nephropathy
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate
Nephrotic Syndrome II : Assessment and Medical Management
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Acute Kidney Injury IV: Diagnostic Studies and Prevention